DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name ▲ | Gene Symbol | Gene ID | Gene Name | UniProt ID |
---|---|---|---|---|---|
C1335473 | Primary chondrosarcoma of bone | IDH2 | 3418 | isocitrate dehydrogenase (NADP(+)) 2 | P48735 |
C0149896 | Primary gout | INPP5D | 3635 | inositol polyphosphate-5-phosphatase D | Q92835 |
C0149896 | Primary gout | CD14 | 929 | CD14 molecule | P08571 |
C0149896 | Primary gout | ALOX5 | 240 | arachidonate 5-lipoxygenase | P09917 |
C0149896 | Primary gout | CYP4F3 | 4051 | cytochrome P450 family 4 subfamily F member 3 | Q08477 |
C0149896 | Primary gout | BCKDHA | 593 | branched chain keto acid dehydrogenase E1 subunit alpha | P12694 |
C0268165 | Primary hyperoxaluria type 2 | GLYCTK | 132158 | glycerate kinase | Q8IVS8 |
C0268165 | Primary hyperoxaluria type 2 | GRHPR | 9380 | glyoxylate and hydroxypyruvate reductase | Q9UBQ7 |
C3150878 | Primary hyperoxaluria type III | HOGA1 | 112817 | 4-hydroxy-2-oxoglutarate aldolase 1 | Q86XE5 |
C0948896 | Primary hypogonadism | PMM2 | 5373 | phosphomannomutase 2 | O15305 |
C0948896 | Primary hypogonadism | CYP17A1 | 1586 | cytochrome P450 family 17 subfamily A member 1 | P05093 |
C0948896 | Primary hypogonadism | GALT | 2592 | galactose-1-phosphate uridylyltransferase | P07902 |
C0948896 | Primary hypogonadism | CYP19A1 | 1588 | cytochrome P450 family 19 subfamily A member 1 | P11511 |
C0948896 | Primary hypogonadism | AMACR | 23600 | alpha-methylacyl-CoA racemase | Q9UHK6 |
C0948896 | Primary hypogonadism | SCP2 | 6342 | sterol carrier protein 2 | P22307 |
C3161650 | Primary immunoglobulin A nephropathy (disorder) | ACE | 1636 | angiotensin I converting enzyme | P12821 |
C3161650 | Primary immunoglobulin A nephropathy (disorder) | SACM1L | 22908 | SAC1 like phosphatidylinositide phosphatase | Q9NTJ5 |
C1306459 | Primary malignant neoplasm | GALNT6 | 11226 | polypeptide N-acetylgalactosaminyltransferase 6 | Q8NCL4 |
C1306459 | Primary malignant neoplasm | PIGU | 128869 | phosphatidylinositol glycan anchor biosynthesis class U | Q9H490 |
C1306459 | Primary malignant neoplasm | B4GALNT2 | 124872 | beta-1,4-N-acetyl-galactosaminyltransferase 2 | Q8NHY0 |
C1306459 | Primary malignant neoplasm | MGAT4A | 11320 | alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A | Q9UM21 |
C1306459 | Primary malignant neoplasm | MGAT4B | 11282 | alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B | Q9UQ53 |
C1306459 | Primary malignant neoplasm | FUT9 | 10690 | fucosyltransferase 9 | Q9Y231 |
C1306459 | Primary malignant neoplasm | ALG3 | 10195 | ALG3 alpha-1,3- mannosyltransferase | Q92685 |
C1306459 | Primary malignant neoplasm | B3GALNT2 | 148789 | beta-1,3-N-acetylgalactosaminyltransferase 2 | Q8NCR0 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024